HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

B Lindholm Selected Research

Inflammation (Inflammations)

11/2014Elevated levels of plasma osteoprotegerin are associated with all-cause mortality risk and atherosclerosis in patients with stages 3 to 5 chronic kidney disease.
1/2014Serum fatty acid patterns, insulin sensitivity and the metabolic syndrome in individuals with chronic kidney disease.
6/2011Plasma osteoprotegerin, arterial stiffness, and mortality in normoalbuminemic Japanese hemodialysis patients.
1/2011The role of epigenetics in kidney diseases.
11/2008Low serum fetuin-A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients.
6/2008Vascular endothelial growth factor in dialysate in relation to intensity of peritoneal inflammation.
5/2008The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality.
3/2008Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients.
2/2008A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease.
12/2007Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


B Lindholm Research Topics

Disease

24Inflammation (Inflammations)
11/2014 - 10/2000
13Chronic Renal Insufficiency
12/2020 - 02/2006
12Malnutrition (Nutritional Deficiencies)
01/2011 - 01/2000
10Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 04/2000
10Chronic Kidney Failure (Chronic Renal Failure)
12/2007 - 04/2000
4Atherosclerosis
11/2014 - 01/2001
4Insulin Resistance
01/2014 - 02/2006
4Peritonitis
06/2008 - 04/2000
4Diabetes Mellitus
05/2007 - 08/2001
3Vascular Calcification
11/2014 - 11/2008
3Peritoneal Fibrosis
11/2007 - 10/2004
2Sarcopenia
02/2008 - 06/2006
2Fibrosis (Cirrhosis)
11/2007 - 10/2004
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
07/2015
1Osteoporosis
02/2015
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2014
1Renal Insufficiency (Renal Failure)
08/2009
1Vascular System Injuries
08/2009
1Weight Loss (Weight Reduction)
02/2008
1Cachexia
02/2008
1Kidney Diseases (Kidney Disease)
02/2008
1Vascular Diseases (Vascular Disease)
07/2007
1Protein-Energy Malnutrition (Marasmus)
06/2006
1Hepatitis C
05/2005
1Anorexia
12/2001
1Hypoalbuminemia
08/2001

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
01/2016 - 01/2000
6Glucose (Dextrose)FDA LinkGeneric
06/2008 - 01/2000
5C-Reactive ProteinIBA
07/2015 - 10/2000
4AlbuminsIBA
07/2015 - 08/2001
4SolutionsIBA
10/2004 - 01/2000
3Interleukin-6 (Interleukin 6)IBA
11/2014 - 02/2003
3alpha-2-HS-GlycoproteinIBA
11/2008 - 07/2005
3Dialysis SolutionsIBA
06/2008 - 04/2000
3Insulin-Like Growth Factor I (IGF-1)IBA
12/2007 - 04/2000
3CytokinesIBA
07/2007 - 10/2000
3HomocysteineIBA
05/2007 - 08/2001
3Biomarkers (Surrogate Marker)IBA
05/2007 - 09/2005
3Icodextrin (Extraneal)FDA Link
01/2001 - 01/2000
2LeptinIBA
07/2015 - 11/2002
2OsteoprotegerinIBA
11/2014 - 06/2011
2VitaminsIBA
01/2011 - 08/2001
2LipopolysaccharidesIBA
06/2008 - 04/2000
2Losartan (Cozaar)FDA LinkGeneric
11/2007 - 10/2004
2Advanced Glycation End ProductsIBA
07/2007 - 12/2006
2DNA (Deoxyribonucleic Acid)IBA
05/2007 - 07/2005
2NitrogenIBA
06/2006 - 01/2000
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2005 - 10/2000
2Serum AlbuminIBA
08/2001 - 10/2000
2CreatinineIBA
04/2000 - 01/2000
1Alkaline PhosphataseIBA
12/2020
1Carnitine (L-Carnitine)FDA LinkGeneric
01/2019
1Betaine (C.B.B.)FDA Link
01/2019
1Choline (Choline Chloride)IBA
01/2019
1trimethyloxamine (trimethylamine N-oxide)IBA
01/2019
1Triglycerides (Triacylglycerol)IBA
07/2015
1HDL CholesterolIBA
07/2015
1AcidsIBA
02/2015
1MineralsIBA
11/2014
1Fibroblast Growth Factor-23IBA
11/2014
1Dietary Fats (Dietary Fat)IBA
01/2014
1Fatty Acids (Saturated Fatty Acids)IBA
01/2014
1Parathyroid Hormone (Parathormone)IBA
06/2011
1AdiponectinIBA
08/2009
1Apolipoproteins B (ApoB)IBA
06/2009
1Apolipoprotein A-I (Apolipoprotein A1)IBA
06/2009
1Acute-Phase Proteins (Acute-Phase Protein)IBA
11/2008
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2008
1antineoplaston A10 (A 10)IBA
03/2008
1CholesterolIBA
02/2008
1Prealbumin (Transthyretin)IBA
02/2008
1Thyroid HormonesIBA
12/2007
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
12/2007
1Rosiglitazone (Avandia)FDA Link
11/2007
1PPAR-gamma AgonistsIBA
11/2007
1Reactive Oxygen Species (Oxygen Radicals)IBA
07/2007
1pentosidineIBA
12/2006
1Insulin-Like Growth Factor Binding Protein 1IBA
06/2006
1Insulin-Like PeptidesIBA
06/2006
1Carrier Proteins (Binding Protein)IBA
06/2006
1Growth Hormone (Somatotropin)IBA
06/2006
1Insulin-Like Growth Factor Binding Protein 3IBA
06/2006
1ResistinIBA
02/2006
1PPAR gammaIBA
09/2005
1Transforming Growth Factors (Transforming Growth Factor)IBA
07/2005
1ApolipoproteinsIBA
07/2005
1Receptor for Advanced Glycation End ProductsIBA
12/2004
1Transforming Growth Factor beta1 (TGF beta 1)IBA
10/2004
1Angiotensin Receptor AntagonistsIBA
10/2004
1Troponin T (Troponin T1)IBA
02/2003
1Leptin ReceptorsIBA
11/2002
1Heparin (Liquaemin)FDA LinkGeneric
03/2001

Therapy/Procedure

8Peritoneal Dialysis
11/2014 - 05/2000
5Renal Dialysis (Hemodialysis)
11/2014 - 04/2000
4Renal Replacement Therapy (Therapies, Renal Replacement)
08/2009 - 07/2005
4Therapeutics
11/2006 - 01/2000
3Continuous Ambulatory Peritoneal Dialysis (CAPD)
12/2004 - 01/2000
1Parenteral Nutrition
08/2009
1Hybrid Renal Replacement Therapy
08/2009
1Continuous Renal Replacement Therapy
08/2009